Syros Pharmaceuticals (SYRS)

Syros Pharmaceuticals (SYRS) Stock Price & Analysis


SYRS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.67 - $14.30
Previous Close$2.77
Average Volume (3M)135.68K
Market Cap
Enterprise Value-$82.50M
Total Cash (Recent Filing)$202.30M
Total Debt (Recent Filing)$63.57M
Price to Earnings (P/E)-0.2
May 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.77
Shares Outstanding20,300,419
10 Day Avg. Volume156,881
30 Day Avg. Volume135,676
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)0.44
Price to Sales (P/S)3.74
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.54
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.94
Price Target Upside788.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Syros Pharmaceuticals’s price range in the past 12 months?
Syros Pharmaceuticals lowest stock price was $2.67 and its highest was $14.30 in the past 12 months.
    What is Syros Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Syros Pharmaceuticals’s upcoming earnings report date?
    Syros Pharmaceuticals’s upcoming earnings report date is May 11, 2023 which is in 43 days.
      How were Syros Pharmaceuticals’s earnings last quarter?
      Syros Pharmaceuticals released its earnings results on Mar 02, 2023. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$1.225 by $1.055.
        Is Syros Pharmaceuticals overvalued?
        According to Wall Street analysts Syros Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Syros Pharmaceuticals pay dividends?
          Syros Pharmaceuticals does not currently pay dividends.
          What is Syros Pharmaceuticals’s EPS estimate?
          Syros Pharmaceuticals’s EPS estimate is -$1.05.
            How many shares outstanding does Syros Pharmaceuticals have?
            Syros Pharmaceuticals has 20,300,419 shares outstanding.
              What happened to Syros Pharmaceuticals’s price movement after its last earnings report?
              Syros Pharmaceuticals reported an EPS of -$0.17 in its last earnings report, beating expectations of -$1.225. Following the earnings report the stock price went up 2.732%.
                Which hedge fund is a major shareholder of Syros Pharmaceuticals?
                Among the largest hedge funds holding Syros Pharmaceuticals’s share is Flagship Pioneering Inc.. It holds Syros Pharmaceuticals’s shares valued at 4M.


                  Syros Pharmaceuticals Stock Smart Score

                  The Syros Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Syros Pharmaceuticals

                  Syros Pharmaceuticals, Inc. engages in the development of novel gene control therapies for cancer and other diseases. It has developed a proprietary platform that is designed to systematically and efficiently analyse unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations. The firm focuses on developing treatments for cancer and immune mediated diseases and is building a pipeline of gene control medicines. The company was founded by Richard A. Young, Nathanael S. Gray and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding SYRS

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold SYRS. The ETFs are listed according to market value of SYRS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Enochian Biosciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis